APA (7th ed.) Citation

Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, & Zhijie Xu. (2024). Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, and Zhijie Xu. Tabersonine Enhances Cisplatin Sensitivity by Modulating Aurora Kinase A and Suppressing Epithelial-mesenchymal Transition in Triple-negative Breast Cancer. Taylor & Francis Group, 2024.

MLA (9th ed.) Citation

Xi Chen, et al. Tabersonine Enhances Cisplatin Sensitivity by Modulating Aurora Kinase A and Suppressing Epithelial-mesenchymal Transition in Triple-negative Breast Cancer. Taylor & Francis Group, 2024.